fasoracetam
Selected indexed studies
- Fasoracetam. LAM 105, NS 105. (Drugs R D, 1999) [PMID:10820660]
- Fasoracetam in adolescents with ADHD and glutamatergic gene network variants disrupting mGluR neurotransmitter signaling. (Nat Commun, 2018) [PMID:29339723]
- A Study of Fasoracetam's Solid State Forms: A Potential Anti-Alzheimer Pharmaceutical. (J Pharm Sci, 2017) [PMID:28109793]
_Worker-drafted node — pending editorial review._
Connections
fasoracetam protects against
Sources
- Fasoracetam. LAM 105, NS 105. (1999) pubmed
- Fasoracetam in adolescents with ADHD and glutamatergic gene network variants disrupting mGluR neurotransmitter signaling. (2018) pubmed
- A Study of Fasoracetam's Solid State Forms: A Potential Anti-Alzheimer Pharmaceutical. (2017) pubmed
- Beyond stimulants: a systematic review of randomised controlled trials assessing novel compounds for ADHD. (2019) pubmed
- Molecular authentication, metabolite profiling and in silico-in vitro cytotoxicity screening of endophytic Penicillium ramusculum from Withania somnifera for breast cancer therapeutics. (2024) pubmed